Movapo Pod TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: apomorphine
Pack: Movapo Pod 100 mg/20 mL injection, 5 x 20 mL cartridges
Brand name
(ARTG)
: MOVAPO POD apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for injection cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
MOVAPO POD is indicated to reduce the number and severity of off phases in patients with Parkinsons disease severely disabled by motor fluctuations refractory to conventional therapy. Initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. Conventional therapy should be continued during on phases.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Subcutaneous
- Clear, colourless to slightly yellow sterile solution, practically free from visible particles.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 5 x 20 mL pre-filled cartridge pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient apomorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
